Gene therapy can be potentially adapted to restore dystrophin expression in Duchenne muscular dystrophy (DMD), an X-linked inherited disease caused by mutations in the gene coding for dystrophin that leads to a life-threatening muscle-wasting condition [252]. Here, DMD is linked to Duchenne muscular dystrophy.